Analysis of Copy Number Loss of the ErbB4 Receptor Tyrosine Kinase in Glioblastoma
Analysis of Copy Number Loss of the ErbB4 Receptor Tyrosine Kinase in Glioblastoma
About this item
Full title
Author / Creator
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
Current treatments for glioblastoma multiforme (GBM), an aggressive form of brain cancer, are minimally effective and yield a median survival of 14.6 months and a two-year survival rate of 30%. Given the severity of GBM and the limitations of its treatment, there is a need for the discovery of novel drug targets for GBM and more personalized treatm...
Alternative Titles
Full title
Analysis of Copy Number Loss of the ErbB4 Receptor Tyrosine Kinase in Glioblastoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071237594
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071237594
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/154815
How to access this item
https://www.proquest.com/docview/2071237594?pq-origsite=primo&accountid=13902
